// App-Quantinova.ai

2661 : AUTO6NG overcomes immune suppressive mechanisms in the TME and demonstrate preclinical anti-tumor activity in GD2-expressing solid tumors

Researchers

Presenter

  • Margarida Neves

Principal Investigators

  • Lukas Stanczuk

  • Alireza Alavi

  • Meggan Czapiga

  • Rebecca Moore

  • Frederick Vargas

  • Muhammad A. Al-Hajj

Medical Centers

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • ADC Therapeutics, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

  • Solid malignancies

  • Melanoma

  • Small cell lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved